Varian Medical Systems (VAR) Tops Q4 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Varian Reports Results for Fourth Quarter of Fiscal Year 2020
October 27, 2020 5:15 PM EDTPALO ALTO, Calif., Oct. 27, 2020 /PRNewswire/ -- Â
Fourth Quarter 2020 Summary
Oncology Systems gross orders of $1.0 billion, down 8% in dollars or 10% in constant currency 10 Ethos orders received, including 5 in North America and 5 in EMEA One Proton order awarded in North America Total company revenues down 3% in dollars, or 4% in constant currency, to $850 million GAAP operating earnings down 11% at 11.6% of revenues; non-GAAP operating earnings declined 10% at 16.8% of revenues GAAP net earnings per diluted share of $0.83; non-GAAP net earnings per diluted share of $1.12 Cash flows from... More